Carregant...

CNOB/ChrR6, a new prodrug enzyme cancer chemotherapy

We report the discovery of a new prodrug, 6-chloro-9-nitro-5-oxo-5Hbenzo[a]phenoxazine (CNOB). This prodrug is efficiently activated by ChrR6, the highly active prodrug activating bacterial enzyme we have previously developed. The CNOB/ChrR6 therapy was effective in killing several cancer cell lines...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Thorne, Steve H., Barak, Yoram, Liang, Wenchuan, Bachmann, Michael H., Rao, Jianghong, Contag, Christopher H., Matin, A.
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2670992/
https://ncbi.nlm.nih.gov/pubmed/19190118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-08-0707
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!